Dashboard
Manage Tickers

VYGR


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
09/30/2025 21:06:48

voyager-therapeutics-alzheimers-portfolio-and-alpl-neuroshuttle-underscore-platform-momentum-analyst
Voyager Therapeutics Alzheimer's Portfolio...
09/15/2025 18:00:31

Voyager's Alzheimer's programs show longer CNS exposure and potential gene therapy advances, with analysts maintaining ...

hc-wainwright--co-reiterates-buy-on-voyager-therapeutics-maintains-30-price-target
HC Wainwright & Co. Reiterates Buy on Voya...
09/15/2025 11:11:51

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Voyager Therapeutics (NASDAQ:VYGR) with a Buy and maintains $...

wedbush-maintains-outperform-on-voyager-therapeutics-lowers-price-target-to-8
Wedbush Maintains Outperform on Voyager Th...
08/07/2025 12:43:09

Wedbush analyst Yun Zhong maintains Voyager Therapeutics (NASDAQ:VYGR) with a Outperform and lowers the price target from $9...

voyager-therapeutics-q2-eps-057-misses-054-estimate-sales-520m-miss-991m-estimate
Voyager Therapeutics Q2 EPS $(0.57) Misses...
08/06/2025 20:52:23

Voyager Therapeutics (NASDAQ:VYGR) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate o...

voyager-therapeutics-introduced-a-wholly-owned-program-that-modulates-the-expression-of-apolipoprotein-e-for-alzheimers-disease
Voyager Therapeutics Introduced A Wholly-O...
07/16/2025 11:02:20

New program combines IV-delivered TRACER capsid with bifunctional payload to silence APOE in carriers of the high-risk APOE4 va...

Core News & Articles
CORRECTION: Voyager Technologies Ticker Is...
06/12/2025 18:49:20

voyager-therapeutics-announces-first-peer-reviewed-publication-of-data-showing-ability-of-alkaline-phosphatase-to-transport-novel-aav-capsid-across-the-blood-brain-barrier
Voyager Therapeutics Announces First Peer-...
05/15/2025 11:07:08

Voyager Therapeutics, Inc. (NASDAQ:VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseas...

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
05/09/2025 21:06:23

voyager-therapeutics-q1-eps-053-misses-046-estimate-sales-647m-miss-1356m-estimate
Voyager Therapeutics Q1 EPS $(0.53) Misses...
05/06/2025 20:42:00

Voyager Therapeutics (NASDAQ:VYGR) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate o...

7-analysts-assess-voyager-therapeutics-what-you-need-to-know
7 Analysts Assess Voyager Therapeutics: Wh...
04/08/2025 18:01:01

hc-wainwright--co-reiterates-buy-on-voyager-therapeutics-maintains-30-price-target
HC Wainwright & Co. Reiterates Buy on Voya...
04/08/2025 17:36:21

HC Wainwright & Co. analyst Patrick Trucchio reiterates Voyager Therapeutics (NASDAQ:VYGR) with a Buy and maintains $30 ...

voyager-unveils-preclinical-data-on-dual-tau-programs-for-alzheimers-ahead-of-adpd-2025
Voyager Unveils Preclinical Data On Dual T...
03/31/2025 11:24:03

- Single IV administration of tau silencing gene therapy VY1706 significantly reduced tau mRNA and protein levels, with broad b...

canaccord-genuity-maintains-buy-on-voyager-therapeutics-lowers-price-target-to-12
Canaccord Genuity Maintains Buy on Voyager...
03/13/2025 16:15:46

Canaccord Genuity analyst Sumant Kulkarni maintains Voyager Therapeutics (NASDAQ:VYGR) with a Buy and lowers the price targe...

hc-wainwright--co-reiterates-buy-on-voyager-therapeutics-maintains-30-price-target
HC Wainwright & Co. Reiterates Buy on Voya...
03/13/2025 10:18:10

HC Wainwright & Co. analyst Patrick Trucchio reiterates Voyager Therapeutics (NASDAQ:VYGR) with a Buy and maintains $30 ...

a-glimpse-into-the-expert-outlook-on-voyager-therapeutics-through-4-analysts
A Glimpse Into The Expert Outlook On Voyag...
03/12/2025 21:04:11

wells-fargo-maintains-overweight-on-voyager-therapeutics-lowers-price-target-to-10
Wells Fargo Maintains Overweight on Voyage...
03/12/2025 15:27:41

Wells Fargo analyst Yanan Zhu maintains Voyager Therapeutics (NASDAQ:VYGR) with a Overweight and lowers the price target fro...

wedbush-reiterates-outperform-on-voyager-therapeuticsto-outperform
Wedbush Reiterates Outperform on Voyager T...
03/12/2025 14:28:42

Wedbush analyst Yun Zhong reiterates Voyager Therapeutics (NASDAQ:VYGR) from Outperform to Outperform.

cantor-fitzgerald-reiterates-overweight-on-voyager-therapeuticsto-overweight
Cantor Fitzgerald Reiterates Overweight on...
03/12/2025 14:11:05

Cantor Fitzgerald analyst Pete Stavropoulos reiterates Voyager Therapeutics (NASDAQ:VYGR) from Overweight to Overweight.

voyager-therapeutics-says-we-expect-our-cash-cash-equivalents-and-marketable-securities-along-with-amounts-expected-to-be-received-as-reimbursement-for-development-costs-under-the-neurocrine-and-novartis-collaborations-and-interest-income-to-be-sufficient-to-meet-voyagers-planned-operating-expenses-and-capital-expenditure-requirements-into-mid-2027
Voyager Therapeutics Says We Expect Our Ca...
03/11/2025 20:05:27

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION